Form D · Biotechnology
Renosome Bio, Inc.
Manchester, CT · CIK 0002040026
Offering snapshot reported Oct 23, 2024 · SEC filing
- Reported sold
- $150K Offering amount: $1M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 8, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2024 | Initial | $150,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527630
Source: Form D, filed Oct 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adam Kievman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
69 Cougar Dr.
Manchester, CT, 06040
Manchester, CT, 06040